Cargando…
A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China
BACKGROUND AND PURPOSE: The response to remission induction in elderly patients with acute myeloid leukemia (AML) remains poor. The purpose of this paper is to evaluate the efficacy and toxicity of a plant alkaloid, homoharringtonine, in combination with cytarabine as an induction therapy for AML in...
Autores principales: | Wang, Jianmin, Lü, Shuqing, Yang, Jianmin, Song, Xianmin, Chen, Li, Huang, Chongmei, Hou, Jun, Zhang, Weiping |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731035/ https://www.ncbi.nlm.nih.gov/pubmed/19642997 http://dx.doi.org/10.1186/1756-8722-2-32 |
Ejemplares similares
-
Homoharringtonine and omacetaxine for myeloid hematological malignancies
por: Lü, Shuqing, et al.
Publicado: (2014) -
PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia
por: Cheng, Hui, et al.
Publicado: (2017) -
FISH(+)CD34(+)CD38(-) cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome
por: Wang, Libing, et al.
Publicado: (2013) -
HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia
por: Hu, Xiaoxia, et al.
Publicado: (2015) -
Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia
por: Shi, Yuanfei, et al.
Publicado: (2022)